Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia ...

Lone-star ticks don’t just pursue and bite people. The affliction they’re spreading, an allergy to red meat known as ...

Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.

New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated Ac ...

CorMedix is shifting from a single-product launch story as DefenCath drives revenue and Rezzayo adds long-term potential ...

Net proceeds anticipated to extend cash runway into first quarter of 2027; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend into second half of 2027 to ...

Lung transplant device LungFX won FDA approval Monday for centralized ex vivo lung perfusion, a technology that reconditions ...

Sofia Donadio, 16, a survivor of the fire at Le Constellation, spoke in Milan about her burns, the operations she underwent ...

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

In patients with acute ischaemic stroke due to anterior-circulation large-vessel occlusion achieving successful reperfusion, ...

For more than 10 years, the stroke research community has sought and investigated drugs that could enhance or strengthen the ...

June 17 (Reuters) - The Trump administration on Wednesday said it would pay $765 million to power project developer Invenergy to terminate four wind leases off the coasts of New York, California and ...